DOCSLIB.ORG

Robotic-Assisted Surgery in Partial Nephrectomy and Cystectomy: a Systematic Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Robotic-Assisted Surgery in Partial Nephrectomy and Cystectomy: a Systematic Review 4 Evidence Synthesis Program Robotic-assisted Surgery in Partial Nephrectomy and Cystectomy: A Systematic Review August 2019 Prepared for: Authors: Department of Veterans Affairs Principal Investigators: Veterans Health Administration Paul G. Shekelle, MD, PhD Health Services Research & Development Service Melinda Maggard-Gibbons, MD Washington, DC 20420 Co-Investigators: Prepared by: Mark Girgis, MD Christopher P. Childers, MD, PhD Evidence Synthesis Program (ESP) Center Amber Tang, BS West Los Angeles VA Medical Center Qiao Ruan, BS Los Angeles, CA Margherita Lamaina, MD Paul G. Shekelle, MD, PhD, Director Research Associates: Selene Mak, PhD, MPH Meron Begashaw, MPH Marika S. Booth, MS 4 Robotic-assisted Surgery in Partial Nephrectomy and Cystectomy Evidence Synthesis Program PREFACE The VA Evidence Synthesis Program (ESP) was established in 2007 to provide timely and accurate syntheses of targeted healthcare topics of importance to clinicians, managers, and policymakers as they work to improve the health and healthcare of Veterans. These reports help: · Develop clinical policies informed by evidence; · Implement effective services to improve patient outcomes and to support VA clinical practice guidelines and performance measures; and · Set the direction for future research to address gaps in clinical knowledge. The program is comprised of four ESP Centers across the US and a Coordinating Center located in Portland, Oregon. Center Directors are VA clinicians and recognized leaders in the field of evidence synthesis with close ties to the AHRQ Evidence-based Practice Center Program and Cochrane Collaboration. The Coordinating Center was created to manage program operations, ensure methodological consistency and quality of products, and interface with stakeholders. To ensure responsiveness to the needs of decision-makers, the program is governed by a Steering Committee comprised of health system leadership and researchers. The program solicits nominations for review topics several times a year via the program website. Comments on this evidence report are welcome and can be sent to Nicole Floyd, Deputy Director, ESP Coordinating Center at [email protected]. Recommended citation: Maggard-Gibbons M, Childers CP, Girgis M, Lamaina M, Tang A, Ruan Q, Mak SS. Begashaw M, Booth MS, Shekelle PG, Robotic-Assisted Surgery in Partial Nephrectomy and Cystectomy. Los Angeles: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs. VA ESP Project #05- 226; 2019. Available at: https://www.hsrd.research.va.gov/publications/esp/reports.cfm. This report is based on research conducted by the Evidence Synthesis Program (ESP) Center located at the West Los Angeles VA Medical Center, Los Angeles, CA, funded by the Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development. The findings and conclusions in this document are those of the author(s) who are responsible for its contents; the findings and conclusions do not necessarily represent the views of the Department of Veterans Affairs or the United States government. Therefore, no statement in this article should be construed as an official position of the Department of Veterans Affairs. No investigators have any affiliations or financial involvement (eg, employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties) that conflict with material presented in the report. i Robotic-assisted Surgery in Partial Nephrectomy and Cystectomy Evidence Synthesis Program ACKNOWLEDGMENTS This topic was developed in response to a nomination by William Gunnar, MD, for the purpose of understanding the potential benefits and costs or robot-assisted surgery. The scope was further developed with input from the topic nominators (ie, Operational Partners), the ESP Coordinating Center, the review team, and the technical expert panel (TEP). In designing the study questions and methodology at the outset of this report, the ESP consulted several technical and content experts. Broad expertise and perspectives were sought. Divergent and conflicting opinions are common and perceived as healthy scientific discourse that results in a thoughtful, relevant systematic review. Therefore, in the end, study questions, design, methodologic approaches, and/or conclusions do not necessarily represent the views of individual technical and content experts. The authors gratefully acknowledge Roberta Shanman, Jon Bergman, and the following individuals for their contributions to this project: Operational Partners Operational partners are system-level stakeholders who have requested the report to inform decision-making. They recommend Technical Expert Panel (TEP) participants; assure VA relevance; help develop and approve final project scope and timeframe for completion; provide feedback on draft report; and provide consultation on strategies for dissemination of the report to field and relevant groups. Mark Wilson, MD National Director of Surgery (10NC2) Department of Veterans Affairs William Gunnar, MD Former National Director of Surgery (10NC2) Department of Veterans Affairs Technical Expert Panel (TEP) To ensure robust, scientifically relevant work, the TEP guides topic refinement; provides input on key questions and eligibility criteria, advising on substantive issues or possibly overlooked areas of research; assures VA relevance; and provides feedback on work in progress. TEP members are listed below: John Gore, MD Associate Professor, Adjunct Associate Professor-Surgery University of Washington Jim C. Hu, MD Professor of Urology, Weill Cornell Medicine Director, LeFrak Center for Robotic Surgery ii Robotic-assisted Surgery in Partial Nephrectomy and Cystectomy Evidence Synthesis Program Mark Jordan, MD Chief of Urology Department of Veterans Affairs, Long Beach John Leppert, MD Associate Professor of Urology, Stanford University Urologist at Palo Alto VA Joe Liao, MD Professor of Urology, Stanford University VA Robotic Surgeon Matthew Rettig, MD Medical Director, Prostate Cancer Program of the Institute of Urologic Oncology, UCLA Professor, Division of Hematology-Oncology and Department of Urology, UCLA Kevin Win, MD Staff Anesthesiology, Department of Veterans Affairs Peer Reviewers The Coordinating Center sought input from external peer reviewers to review the draft report and provide feedback on the objectives, scope, methods used, perception of bias, and omitted evidence. Peer reviewers must disclose any relevant financial or non-financial conflicts of interest. Because of their unique clinical or content expertise, individuals with potential conflicts may be retained. The Coordinating Center and the ESP Center work to balance, manage, or mitigate any potential nonfinancial conflicts of interest identified. iii Robotic-assisted Surgery in Partial Nephrectomy and Cystectomy Evidence Synthesis Program TABLE OF CONTENTS ACKNOWLEDGMENTS ........................................................................................................... II EXECUTIVE SUMMARY .......................................................................................................... 7 Introduction .................................................................................................................................. 7 Methods........................................................................................................................................ 7 Data Sources and Searches .......................................................................................................... 8 Study Selection ............................................................................................................................ 8 Data Abstraction and Quality Assessment ................................................................................... 8 Data Synthesis and Analysis ........................................................................................................ 8 Results .......................................................................................................................................... 8 Results of Literature Search ......................................................................................................... 8 Summary of Results for Key Questions ....................................................................................... 8 Discussion .................................................................................................................................. 10 Key Findings and Strength of Evidence .................................................................................... 10 Applicability .............................................................................................................................. 10 Research Gaps/Future Research ................................................................................................ 10 Conclusions ................................................................................................................................ 10 Abbreviations Table ................................................................................................................... 11 EVIDENCE REPORT ................................................................................................................ 12 INTRODUCTION......................................................................................................................
Load more

Recommended publications
  • What a Difference a Delay Makes! CT Urogram: a Pictorial Essay
    Abdominal Radiology (2019) 44:3919–3934 https://doi.org/10.1007/s00261-019-02086-0 SPECIAL SECTION : UROTHELIAL DISEASE What a diference a delay makes! CT urogram: a pictorial essay Abraham Noorbakhsh1 · Lejla Aganovic1,2 · Noushin Vahdat1,2 · Soudabeh Fazeli1 · Romy Chung1 · Fiona Cassidy1,2 Published online: 18 June 2019 © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2019 Abstract Purpose The aim of this pictorial essay is to demonstrate several cases where the diagnosis would have been difcult or impossible without the excretory phase image of CT urography. Methods A brief discussion of CT urography technique and dose reduction is followed by several cases illustrating the utility of CT urography. Results CT urography has become the primary imaging modality for evaluation of hematuria, as well as in the staging and surveillance of urinary tract malignancies. CT urography includes a non-contrast phase and contrast-enhanced nephrographic and excretory (delayed) phases. While the three phases add to the diagnostic ability of CT urography, it also adds potential patient radiation dose. Several techniques including automatic exposure control, iterative reconstruction algorithms, higher noise tolerance, and split-bolus have been successfully used to mitigate dose. The excretory phase is timed such that the excreted contrast opacifes the urinary collecting system and allows for greater detection of flling defects or other abnormali- ties. Sixteen cases illustrating the utility of excretory phase imaging are reviewed. Conclusions Excretory phase imaging of CT urography can be an essential tool for detecting and appropriately characterizing urinary tract malignancies, renal papillary and medullary abnormalities, CT radiolucent stones, congenital abnormalities, certain chronic infammatory conditions, and perinephric collections.
    [Show full text]
  • Thromboprophylaxis in Urological Surgery
    EAU Guidelines on Thromboprophylaxis in Urological Surgery K.A.O. Tikkinen (Chair), R. Cartwright, M.K. Gould, R. Naspro, G. Novara, P.M. Sandset, P. D . Violette, G.H. Guyatt © European Association of Urology 2018 TABLE OF CONTENTS PAGE 1. INTRODUCTION 3 1.1 Aims and objectives 3 1.2 Panel composition 3 1.3 Available publications 3 1.4 Publication history 3 2. METHODS 3 2.1 Guideline methodology 3 3. GUIDELINE 4 3.1 Thromboprophylaxis post-surgery 4 3.1.1 Introduction 4 3.1.2 Outcomes and definitions 4 3.1.3 Timing and duration of thromboprophylaxis 4 3.1.4 Basic principles for recommending (or not recommending) post-surgery thromboprophylaxis 5 3.1.4.1 Effect of prophylaxis on key outcomes 5 3.1.4.2 Baseline risk of key outcomes 5 3.1.4.3 Patient-related risk (and protective) factors 5 3.1.4.4 From evidence to recommendations 6 3.1.5 General statements for all procedure-specific recommendations 7 3.1.6 Recommendations 7 3.2 Peri-operative management of antithrombotic agents in urology 14 3.2.1 Introduction 14 3.2.2 Evidence summary 14 3.2.3 Recommendations 14 4. RESEARCH RECOMMENDATIONS 16 5. REFERENCES 16 6. CONFLICT OF INTEREST 18 7. ACKNOWLEDGEMENTS 18 8. CITATION INFORMATION 18 2 THROMBOPROPHYLAXIS - MARCH 2017 1. INTRODUCTION 1.1 Aims and objectives Due to the hypercoagulable state induced by surgery, serious complications of urological surgery include deep vein thrombosis (DVT) and pulmonary embolism (PE) - together referred to as venous thromboembolism (VTE) - and major bleeding [1-4].
    [Show full text]
  • Effective Endoscopic Holmium Laser Lithotripsy in the Treatment of a Large
    Cases and Techniques Library (CTL) E485 The patient was discharged after 15 days with complete resolution of the occlusive Effective endoscopic holmium laser lithotripsy symptoms, and her scheduled chole- in the treatment of a large impacted gallstone cystectomy was canceled. in the duodenum Endoscopy_UCTN_Code_CCL_1AZ_2AD Competing interests: None Fig. 1 Computed tomographic scan shows a large calcified Vincenzo Mirante, Helga Bertani, ring (stone) in the Giuseppe Grande, Mauro Manno, duodenum of an Angelo Caruso, Santi Mangiafico, 87-year-old woman Rita Conigliaro presenting with ab- U.O.C. Gastroenterology and Digestive dominal pain and vomiting of 3 days’ Endoscopy Unit, Nuovo Ospedale Civile duration. Sant'Agostino Estense, Modena, Italy References 1 Reisner RM, Cohen JR. Gallstone ileus: a re- view of 1001 reported cases. Am Surg 1994; 60: 441–446 2 Rodriguez H, Codina C, Girones V et al. Gall- stone ileus: results of analysis of a series of Gallstone ileus is caused by the passage To fragment the stone, we performed an- 40 patients. Gastroenterol Hepatol 2001; – of one or more large gallstones (at least other endoscopic procedure. A holmium 24: 489 494 3 Rigler LG, Borman CN, Noble JF. Gallstone ob- 2.5 cm in size) in the gastrointestinal tract laser (HLS30W Holmium:YAG 30W Laser; struction: pathogenesis and roentgen mani- through a bilioenteric fistula. It accounts Olympus America, Center Valley, Penn- festations. JAMA 1941; 117: 1753 –1759 for 1 % to 4% of all cases of mechanical sylvania, USA) was applied for a total of 4 Goldstein EB, Savel RH, Pachter HL et al. Suc- small-bowel obstruction [1,2].
    [Show full text]
  • Cystectomy and Neo Bladder Surgery
    Form: D-5379 Cystectomy and Neo Bladder Surgery A guide for patients and families Reading this booklet can help you prepare for your surgery, hospital stay and recovery after surgery. We encourage you to take an active role in your care. If you have any questions, please ask a member of your health care team. Inside this booklet page Learning about your surgery ...................................................3 Preparing for surgery ...............................................................5 Your hospital stay ......................................................................9 Getting ready to leave the hospital .........................................17 Your recovery after surgery .....................................................19 Who to call if you have questions ............................................29 When to get medical help ........................................................30 2 Learning about your surgery What is a Cystectomy? Cystectomy is surgery to remove your bladder. This is usually done to control bladder cancer. Depending on the extent of the cancer, the bladder and some surrounding organs may need to be removed. • The prostate gland, seminal vesicles and nerve bundles may also be removed. • The ovaries, fallopian tubes, uterus, cervix and part of the vagina may also be removed. What is a Neo Bladder? Words to know A neo bladder is a pouch made from a Neo means new. piece of your bowel that is placed where A neo bladder is a new bladder. your bladder was removed. A neo bladder is commonly called a pouch, because a piece The pouch acts like a bladder, collecting of your bowel is made into a urine that comes down the ureters from pouch that can store urine. the kidneys. When you pass urine, it The medical name for this is a leaves the pouch through your urethra.
    [Show full text]
  • Comparison of Postoperative Renal Function Between Non-Steroidal
    Journal of Clinical Medicine Article Comparison of Postoperative Renal Function between Non-Steroidal Anti-Inflammatory Drug and Opioids for Patient-Controlled Analgesia after Laparoscopic Nephrectomy: A Retrospective Cohort Study Jiwon Han 1 , Young-Tae Jeon 1,2, Ah-Young Oh 1,2 , Chang-Hoon Koo 1, Yu Kyung Bae 1 and Jung-Hee Ryu 1,2,* 1 Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, 82, Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13620, Korea; [email protected] (J.H.); [email protected] (Y.-T.J.); [email protected] (A.-Y.O.); [email protected] (C.-H.K.); [email protected] (Y.K.B.) 2 Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, 103, Daehak-ro, Jongno-gu, Seoul 03080, Korea * Correspondence: [email protected]; Tel.: +82-31-787-7497 Received: 7 August 2020; Accepted: 9 September 2020; Published: 13 September 2020 Abstract: Non-steroidal anti-inflammatory drugs (NSAIDs) can be used as opioid alternatives for patient-controlled analgesia (PCA). However, their use after nephrectomy has raised concerns regarding possible nephrotoxicity. This study compared postoperative renal function and postoperative outcomes between patients using NSAID and patients using opioids for PCA in nephrectomy. In this retrospective observational study, records were reviewed for 913 patients who underwent laparoscopic or robot-assisted laparoscopic nephrectomy from 2015 to 2017. After propensity score matching, 247 patients per group were analyzed. Glomerular filtration rate (GFR) percentages (postoperative value divided by preoperative value), blood urea nitrogen (BUN)/creatinine ratios, and serum creatinine percentages were compared at 2 weeks, 6 months, and 1 year after surgery between users of NSAID and users of opioids for PCA.
    [Show full text]
  • Laparoscopic Nephrectomy
    Laparoscopic Nephrectomy Information for Patients This leaflet explains: What is a Nephrectomy? ............................................................................................. 2 Why do I need a nephrectomy? ................................................................................... 3 What are the risks and side effects of laparoscopic nephrectomy? ............................. 3 Occasional risks ....................................................................................................... 3 Rare risks ................................................................................................................. 3 Very Rare Risks ....................................................................................................... 3 Before the operation .................................................................................................... 4 Day of your operation .................................................................................................. 4 How long will the operation take? ................................................................................ 4 After the operation ....................................................................................................... 4 Going home ................................................................................................................. 5 At home ....................................................................................................................... 5 Contacts .....................................................................................................................
    [Show full text]
  • (Part 1): Management of Male Urethral Stricture Disease
    EURURO-9412; No. of Pages 11 E U R O P E A N U R O L O G Y X X X ( 2 0 2 1 ) X X X – X X X ava ilable at www.sciencedirect.com journa l homepage: www.europeanurology.com Review – Reconstructive Urology European Association of Urology Guidelines on Urethral Stricture Disease (Part 1): Management of Male Urethral Stricture Disease a, b c d Nicolaas Lumen *, Felix Campos-Juanatey , Tamsin Greenwell , Francisco E. Martins , e f a c g Nadir I. Osman , Silke Riechardt , Marjan Waterloos , Rachel Barratt , Garson Chan , h i a j Francesco Esperto , Achilles Ploumidis , Wesley Verla , Konstantinos Dimitropoulos a b Division of Urology, Gent University Hospital, Gent, Belgium; Urology Department, Marques de Valdecilla University Hospital, Santander, Spain; c d Department of Urology, University College London Hospital, London, UK; Department of Urology, Santa Maria University Hospital, University of Lisbon, e f Lisbon, Portugal; Department of Urology, Sheffield Teaching Hospitals, Sheffield, UK; Department of Urology, University Medical Center Hamburg- g h Eppendorf, Hamburg, Germany; Division of Urology, University of Saskatchewan, Saskatoon, Canada; Department of Urology, Campus Biomedico i j University of Rome, Rome, Italy; Department of Urology, Athens Medical Centre, Athens, Greece; Aberdeen Royal Infirmary, Aberdeen, UK Article info Abstract Article history: Objective: To present a summary of the 2021 version of the European Association of Urology (EAU) guidelines on management of male urethral stricture disease. Accepted May 15, 2021 Evidence acquisition: The panel performed a literature review on these topics covering a time frame between 2008 and 2018, and used predefined inclusion and exclusion criteria Associate Editor: for the literature to be selected.
    [Show full text]
  • Infectious and Inflammatory Complications (IIC) in Patients
    e3640 European Urology Supplements 18 (12), (2019), e3621–e3646 pediatric patients; moreover, we did not find literature with the results GUA-46 Choice of the method of draining the urinary tract of extracorporeal shock wave lithotripsy (ESWL) use. in residual stones after percutaneous Materials and methods: From January 2015 to November 2018 ESWL nephrolithomy in children was performed on an emergency basis to 124 children with renal colic which could not be treated with non-steroidal anti-inflammatory Y. S. Nadjimitdinov, Sh. T. Mukhtarov, Sh. Abbosov drugs or recurred repeatedly during 24 hours. Mean age was 9.5 ± 1.6, – Tashkent Medical Academy, Department of Urology, Tashkent, 83 were boys and 41 girls. Intravenous urography was done only in Uzbekistan the cases when there were doubts in stone size and level of its situation according to the plain urography. Before ESWL children’s parents were informed about the method and its complications and possible Background: To date, percutaneous nephrolithotomy (PCNLT) is the manipulations in the urinary tract if necessary (ureteral stenting, method of choice in patients with urolithiasis. This method has proven endoscopic removal of stone fragments) or repeated lithotripsy. to be completely safe and effective in treating children with Results: Ambulant help was rendered to 21 patients; 103 patients nephrolithiasis. However, in some cases, for various reasons, it is not were hospitalized for 1 day. Stone size more than 10 mm (mean size possible using the endoscopic method to completely rid the patient of 14.2 ± 0.8 mm) was revealed in 48 patients. In 76 cases maximum calculi located in the kidney cavities.
    [Show full text]
  • Continent Urinary Reservoirs and Bladder Substitutes.Pdf
    ������������������ ��������������� ������������������� �������������������� ���������������� ��������������������� Continent Cutaneous Urinary Reservoirs and Bladder Substitutes Anatomy The bladder is an organ in the pelvis that collects, stores and expels urine. Urine is produced by the kidneys and travels down two tube-like structures called the ureters. The ureters connect the kidneys to the bladder. Urine leaves the bladder through another tube-like structure called the urethra. (Figure 1) Removal of the bladder (cystectomy) may be necessary in some people with bladder cancer, congenital disor- ders of the urinary tract, and in some people who have suffered surgical, traumatic or neurologic damage to the bladder. In these situations, another method of col- lecting and excreting urine must be found. The most common and easiest method for urinary diversion is to use a short piece of intestine as the connection between the ureters and the outside of the body (ileal or colon conduit). This type of diversion is easy for the patient to manage and has a low rate of complication. However, an ostomy bag must be worn at all times to collect urine. Newer surgical techniques are available which do not require the patient to wear an ostomy bag. These newer proce- dures involve creation of a continent urinary reser- voir that collects and stores urine. What is a Continent Urinary Reservoir and How is it Made? A continent urinary reser- voir is an internal “pouch” made from segments of the intestine. Urinary reservoirs can be made from small intestine alone, large intestine alone or from a combination of the above. (Figure 2) The bowel segments selected for use are disconnected from the remainder of the intestinal tract to avoid mixing the gastrointestinal contents (feces) with urine.
    [Show full text]
  • Pyelography in Infants
    Arch Dis Child: first published as 10.1136/adc.9.50.119 on 1 April 1934. Downloaded from PYELOGRAPHY IN INFANTS BY W. E. UNDERWOOD, F.R.C.S., Chief Assistant to a Surgical Unit, St. Bartholomew's Hospital. Pyelography in infants is an examination which is essential under certain circumstances, and from it valuable facts may often be obtained which would be undiscovered without this specialized form of investigation. Hitherto the examination has been surrounded by difficulties of such a nature that it is often unsuccessful and the child is submitted to discomfort without result. The object of this paper is to bring forward certain notes on cases where pyelography has been indicated. The observations from a series of sixteen cases have led to the development of a method whereby good pyelograms have been obtained with certainty. Instrumental pyelography in infancy is a procedure not to be advised lightheartedly, but there are occasions where the indications are definite and adequate: in these cases the anticipation of possible information to be gained justifies submitting the infants to what constitutes a major examination. In this series are cases of urinary infection resistant to the usual medical treatment, of renal pain, of renal calculi, and cases of congenital malformation http://adc.bmj.com/ of the urinary tract similar to those described by Poynton and Sheldon'. The term pyelography is used here for brevity rather than accuracy, for it embraces a complete investigation of the urinary tract, including ureterography. Methods of pyelography.-The choice lies between intravenous and on September 30, 2021 by guest.
    [Show full text]
  • Dr. Alexander Kutikov: Yeah
    Question and Answer Stephanie Chisolm: I deeply thank you so much. Dr. Kutikov, that was phenomenal and I think you really did such a great job of explaining all of those complications and everything else. I think the underlying message that I heard, and I hope that the participants here is kind of you wouldn't take your Jaguar to the mechanic on the corner. You go to somebody that does this on a regular basis. You really want to go to somebody who has that experience if you're going to have the surgery, because it is complicated. You don't want them to say, "I read about that in a journal once." Then, "Sure, I can do that. I'm a doctor." You want to go with somebody who has an awareness of what the problems are so you can circumvent them certainly. I think that that came through very closely and very clearly. Let's get to some of the questions. We have a kind of a unique question. There's a participant with only one kidney and their GFR is holding at 27. I guess they're indicating that they're going to have a cystectomy. If they choose to have the stoma and need dialysis, I think this is a good recommendation in terms of getting in the team approach. Because dialysis can be run by the nephrologist, correct? Is it possible to do dialysis when you only have a stoma? Dr. Alexander Kutikov: Yeah. Hemodialysis, the stoma won't affect your hemodialysis. I think the question is asking whether they can do peritoneal dialysis, which is basically putting dialysis fluid in the belly and having an exchange and do what a kidney does, but filter the toxins through the peritoneum.
    [Show full text]
  • The Morbidity Due to Lower Urinary Tract Function in Spinal Cord Injury Patients
    Paraplegia 31 (1993) 320-329 © 1993 International Medical Society of Paraplegia The morbidity due to lower urinary tract function in spinal cord injury patients P E V Van Kerrebroeck MD PhD, E L Koldewijn MD, S Scherpcnhuizen, F M J Debruyne MD PhD Department of Urology, Unit for Neurourology and Urodynamics, University Hospital St Radboud, Geert Grooteplein Zuid 16, PO Box 9101, NL-6500 HB Nijmegen, The Netherlands. A review is given of 105 patients with a traumatic spinal cord injury. In 93 patients with a minimum follow up of one year the morbidity due to lower urinary tract function was evaluated, based on the situation at their last control visit. The relation was studied between bladder behaviour and the type of urine evacuation and their influence on upper urinary tract problems, urinary tract infections, stone formation and incontinence. Based on the results of this study the most appropriate method for control of bladder behaviour and urine evacuation in spinal cord injured patients is discussed in view of new treatment modalities such as dorsal rhizotomies and the implantation of an anterior sacral root stimulator. Keywords: spinal cord injuries; neurogenic lower urinary tract dysfunction; morbidity. Introduction daily practice proves that the control of individual patients tends to be less scrupul­ Great progress has been made during the ous with time. Even in the published pros­ last 25 years in the urological rehabilitation pective series the incidence of urological of patients with a spinal cord injury. problems varies much depending on the Nevertheless these patients continue to follow up, the composition of the patient develop complications such as urinary groups and the treatment(s) that were prop­ tract infections, stones of the upper and osed.
    [Show full text]